A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
Giovarelli M, Musiani P, Garotta G, Ebner R, Di Carlo E, Kim Y, Cappello P, Rigamonti L, Bernabei P, Novelli F, Modesti A, Coletti A, Ferrie AK, Lollini PL, Ruben S, Salcedo T, Forni G.
Giovarelli M, et al. Among authors: cappello p.
J Immunol. 1999 Nov 1;163(9):4886-93.
J Immunol. 1999.
PMID: 10528190